ロード中...
COVID‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain
Immunosuppressive and immunomodulatory treatments are critical for the management of inflammatory and autoimmune conditions such as psoriasis or psoriatic arthritis. Similar to those illnesses, the lung injury and acute respiratory distress shown in coronavirus disease 2019 (COVID‐19) patients are t...
保存先:
| 出版年: | Dermatol Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361149/ https://ncbi.nlm.nih.gov/pubmed/32618402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13961 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|